Nov. 7, 2020 – Currently available medication-assisted treatments for opioid use disorder include methadone, buprenorphine and naltrexone. According to Sauvé, methadone allows those with opioid use disorder to discontinue heroin use without experiencing withdrawal symptoms. It is available through specialty clinics, to which patients must make daily visits, and is linked to an increased risk for respiratory depression. Buprenorphine has appeared associated with active withdrawal symptoms among individuals currently using prescription opioids or heroin, so Sauvé emphasized that patients should be experiencing at least some mild withdrawal prior to starting buprenorphine. Although specialty licensing for the prescriber is required, it does not need to be administered at specialty clinics, and the risk for respiratory depression is lower compared to methadone.
GIVING BACK IN STYLE – April 17, 2024 - “It’s still one day at…
RIDING THE WAVE...CALMLY – April 18, 2024 - “I was 13 years old and…
VIDEO – NEW YORK STORIES – April 23, 2024 - Sara Gettelfinger had steadily…
TRY IT, YOU’LL LIKE IT – April 18, 2024 - The rise in “sober…
AUDIO – SOBER MEN CAN DO THAT – April 4, 2024 - Acting icon…
I’LL BET HE GOES TO GA (not Georgia) – April 13, 2024 -The initial…